Review Article
Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease
Table 1
Clinical trials of gene therapy in peripheral artery diseases.
| Authors | Year | Gene | Vector | Delivery route | | Reference number |
| Baumgartner et al. | 1998 | VEGF165 | naked pDNA | IM | 9 | [4] | Isner et al. | 1998 | VEGF165 | naked pDNA | IM | 6 | [5] | Rajagopalan et al. | 2001 | VEGF121 | adenovirus | IM | 5 | [7] | Mäkinen et al. | 2002 | VEGF165 | adenovirus, plasmid/liposome | IA | 54 | [6] | Comerota et al. | 2002 | FGF-1 | naked pDNA | IA | 51 | [11] | Rajagopalan et al. | 2003 | VEGF121 | adenovirus | IM | 1 : 1 : 1 fashion to low dose, high dose, or placebo arms (35-36 patients in each group) | [9] | Kusumanto et al. | 2006 | VEGF165 | naked pDNA | IM | 54 | [8] | Nikol et al. | 2008 | FGF-1 | naked pDNA | IM | 125 | [12] | Shigematsu et al. | 2010 | HGF | naked pDNA | IM | 44 | [13] | Belch et al. | 2011 | FGF-1 | naked pDNA | IM | 525 | [14] | Morishita et al. | 2011 | HGF | naked pDNA | IM | 22 | [15] |
|
|
VEGF: vascular endothelial growth factor; FGF: fibroblast growth factor (FGF); HGF: hepatocyte growth factors.
|